CSPC Innovation Pharma
a subsidiary of CSPC Pharmaceutical Group, manufactures caffeine, theobromine and other methylxanthine APIs for global pharmaceutical supply, with DMF registrations supporting exports to regulated markets.
- Country
- China
- Ticker
- HKEX:1093
Commercial
Caffeine & theobromine API; DMF-registered; HKEX: 1093; founded 1992
cn
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic theobromine | specialty-fine-chem | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.